Molecular biology of retinal development and retinal degeneration
Molecular biology of retinal development and retinal degeneration
批准号:
09671787
负责人:
YAMASHITA Hidetoshi
金额:
$1.92万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1997
资助国家:
日本
项目状态:
已结题
起止时间:
1997 至 1998
中文摘要
为探讨TGF-β超家族在视网膜发育中的作用,采用免疫组织化学方法观察了正常大鼠视网膜发育过程中TGF-β超家族受体表达的变化。激活素I型受体和BMP IB型受体首先分别在P6和P3视网膜中以蛋白质水平检测到,并且激活素II型受体首先在P0视网膜中检测到。其他受体(TGF-β I型和II型受体、激活素IB型受体、BMP IA型和II型受体)在E17时检测到。PO-P9期与大鼠视网膜发育的动态变化相一致。这些结果表明,TGF-β超家族的表达沿着视网膜的发育,可能与视网膜的发育有关。RB细胞系由于TGF-β与RB细胞结合的缺乏而对TGF-β具有抗性。为了阐明耐药机制, ...更多信息 针对TGF-β,我们研究了TGF-β受体和Smad家族(TGF-β家族的转换器)在细胞系中的表达,以及TGF-β RB的信号转导途径。在RB细胞系中,TGF-β I型或II型受体(分别为TbetaR-I、TbetaR-II)在细胞表面上不表达。表达TbetaR-I mRNA。未检测到TbetaR-II mRNA,但丁酸钠可诱导TbetaR-II mRNA的表达。突变分析显示TbetaR-II基因编码区无突变。表达Smad家族成员mRNA(Smad 2、3、4)。通过TGF-β添加的转录激活仅通过TbetaR-I和TbetaR-II两者的转染来拯救。对TGF-β的应答的缺乏是由细胞表面上TGF-β受体表达的缺乏引起的。RB细胞中某些信号转导通路是保守的,为探讨RCS大鼠视网膜变性的发病机制,研究RB细胞胞浆内凋亡信号转导分子的表达。凋亡信号调节激酶1(ASK 1)参与丝裂原活化蛋白(MAP)激酶级联反应。p38和具有MAP激酶活性的c-Jun-氨基末端激酶(JNK)是ASK 1的下游组分。4 W和5 W的RCS大鼠视网膜,p38和JNK在两个RCS大鼠的内节中表达。而RCS大鼠视网膜光感受器细胞内节区ASK 1、p38-p和JNK-p的表达均显著降低,提示RCS大鼠视网膜光感受器细胞内ASK 1通过p38和/或JNK的信号转导被阻断。RCS大鼠视网膜光感受器细胞中ASK 1通过p38和/或JNK的信号转导被阻断。少
英文摘要
To ascertain the roles of TGF-beta superfamily in retinal development, the changes of the expression patterns of these receptors during development of the normal rat retina were observed immunohistochemically. Activin type I receptor and BMP type IB receptor were first detected in P6 and P3 retinas at protein levels, respectively, and activin type II receptor was First detected in P0 retina The other receptors (TGF-beta type I and II receptors, activin type IB receptor, BMP type IA and II receptors) were detected at E17. The period of PO-P9 corresponded to the dynamic changes in the rat retinal development. These results suggest that the expression of TGF-beta superfamily is regulated along with retinal development and may be related to retinal developmentTo investigate molecular mechanisms of retinal precursor cells, retinoblastoma (RB) cell lines were used. RB cell lines are resistant to TGF-beta due to the absence of TGF-beta binding to RB cells. To elucidate the mechanisms of resis … More tance to TGF-beta, we studied the expression of TGF-beta receptors and Smad family (transducers for TGF-beta family), and signal transduction pathways for TGF-beta RB in cell lines. In RB cell lines, either TGF-beta type I or II receptors (TbetaR-I, TbetaR-II, respectively) was not expressed on the cell surface. TbetaR-I mRNA was expressed. TbetaR-II mRNA was not detected, however, was induced by sodium butyrate. Mutation analysis revealed no mutation in the coding region of TbetaR-II gene. Smad family member mRNAs (Smad 2, 3, 4) were expressed. Transcription activation by TGF-beta addition was rescued only by the transfection of both TbetaR-I and TbetaR-II.The lack of response to TGF-beta is caused by the lack of TGF-beta receptor expression on cell surface. Some parts of signal transduction pathways are conserved in RB cells.To investigate pathogenesis of retinal degeneration in Royal College of Surgeons (RCS) rats in vivo, the expression of intracytoplasmic signal transducers for apoptosis. Apoptosis signal-regulating kinase 1 (ASK1) in involved in the mitogen-activated protein (MAP) kinase cascade. p38 and c-Jun-amino-terminal kinase (JNK) with MAP kinase activity were downstream component of ASK1. RCS rat retina of 4W and 5W, p38 and JNK were expressed in the inner segments in both RCS rats. However, the expression of ASK1, p38-p or JNK-p in the inner segments decreased significantly in RCS rats, which suggests that the signal transduction from ASK1 through p38 and/or JNK was abrogated in RCS rat retinal photoreceptor cells. Signal transduction from ASK1 through p38 and/or JNK was abrogated in retinal photoreceptor cells in RCS rat. Less
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Yamada H.et al.: "Expression of transferming growth factor-β supertawily receptors in developing rat eyes." Jpn J Ophthalmol. (印刷中).
Yamada H. 等人:“转移生长因子-β supertawily 受体在发育中的大鼠眼睛中的表达。”Jpn J Ophamol。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Usui T.et al.: "Molecular mechanism of extracellular matrix production by transforming growth factor-β in corneal endothelial cells." Invest.Ophthalmol.Vis.Sci. 39. 1981-1989 (1998)
Usui T. 等人:“通过转化角膜内皮细胞中的生长因子-β 产生细胞外基质的分子机制。” Invest.Ophthalmol.Vis.Sci 39. 1981-1989 (1998)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
山下英俊: "トランスフォーミング増殖因子ベータスーパーファミリーの眼組織における作用" 日本眼科学会雑誌. 101. 927-947 (1997)
Hidetoshi Yamashita:“转化生长因子β超家族对眼组织的影响”日本眼科学会杂志 101. 927-947 (1997)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Mita T.et al.: "Effects of transforming growth factor-β on corneal epithelial and stromal cell function in rat wound healing model." Graefe's Arch Clin Exp Ophthalmol. 236. 834-843 (1998)
Mita T. 等人:“转化生长因子-β 对大鼠伤口愈合模型中角膜上皮和基质细胞功能的影响。”Graefes Arch Clin Exp Ophthalmol。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Usui T.et al.: "Molecular mechanism of extracellular matrix production by transforming growth factor-β in corneal endcthelial cells." Invest Ophthalmol Vis Sci. 39. 1981-1989 (1998)
Usui T. 等人:“通过转化角膜内皮细胞中的生长因子-β 产生细胞外基质的分子机制。” Invest Ophasemol Vis Sci。 39. 1981-1989 (1998)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 6 条
Comprehensive Social Scientific Study on Radioactive Waste Disposal Issues
-
批准号:19H04335
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.4万
-
财政年份:2019
-
负责人:YAMASHITA Hidetoshi
-
依托单位:
Molecular epidemiological study on choroidopathy in diabetic eyes
-
批准号:18K09439
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.91万
-
财政年份:2018
-
负责人:YAMASHITA Hidetoshi
-
依托单位:
Molecular mechanisms of progression of diabetic retinopathy focusing inflammatory mechanisms by dendritic cells in vitreous
-
批准号:15K10832
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.08万
-
财政年份:2015
-
负责人:YAMASHITA Hidetoshi
-
依托单位:
Research on policies for the promotion of locally initiated renewable energy projects
-
批准号:25281068
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.4万
-
财政年份:2013
-
负责人:YAMASHITA Hidetoshi
-
依托单位:
Molecular pathogenesis and strategic approach of treatment for diabetic retinopathy
-
批准号:24592617
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.33万
-
财政年份:2012
-
负责人:YAMASHITA Hidetoshi
-
依托单位:
New strategy to treat diabetic retinopathy using stabilization of hyalocyte-vasucular endothelial cell correlation
-
批准号:21592215
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.91万
-
财政年份:2009
-
负责人:YAMASHITA Hidetoshi
-
依托单位:
An analysis of the effects of the waste tax on the reduction of the final disposal of industrial wastes
-
批准号:20710036
-
项目类别:Grant-in-Aid for Young Scientists (B)
-
资助金额:$2.75万
-
财政年份:2008
-
负责人:YAMASHITA Hidetoshi
-
依托单位:
Changes of retinal vascular structure in diabetic retinopathy andstrategy of treatment
-
批准号:19592004
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.91万
-
财政年份:2007
-
负责人:YAMASHITA Hidetoshi
-
依托单位:
Molecular Mechanisms of Damage to Retinal Neuronal Cells in Diabetic Retinopathy and New Therapeutic Modalities
-
批准号:17591819
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.24万
-
财政年份:2005
-
负责人:YAMASHITA Hidetoshi
-
依托单位:
Determination of treatment modalities for diabetic retinopathy and diabetic maculopathy -Strategic approach using molecular and cellular biological methods-
-
批准号:15591841
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.24万
-
财政年份:2003
-
负责人:YAMASHITA Hidetoshi
-
依托单位:
Mutation analysis of tumors in ophthalmological area to to choose the treatment modalities---mutation analysis using paraffin specimens---
-
批准号:13671819
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.24万
-
财政年份:2001
-
负责人:YAMASHITA Hidetoshi
-
依托单位:
Development of therapeutic agents and gene therapy by inhibiting new vessel formation
-
批准号:11671724
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.5万
-
财政年份:1999
-
负责人:YAMASHITA Hidetoshi
-
依托单位:
MOLECULAR MECHANISMS OF CORNEAL WOUND HEALING AFTER PHOTO-REFRACTIVE CORNEAL SURGERY
-
批准号:11557127
-
项目类别:Grant-in-Aid for Scientific Research (B).
-
资助金额:$8.64万
-
财政年份:1999
-
负责人:YAMASHITA Hidetoshi
-
依托单位:
Molecular mechanisms of ocular angiogenesis and development of therpeutic agents
-
批准号:09557136
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$7.68万
-
财政年份:1997
-
负责人:YAMASHITA Hidetoshi
-
依托单位:
Development of New Immunotherapy in Ophthalmology
-
批准号:60440079
-
项目类别:Grant-in-Aid for General Scientific Research (A)
-
资助金额:$21.18万
-
财政年份:1985
-
负责人:YAMASHITA Hidetoshi
-
依托单位:
国内基金
海外基金
登录
查看更多内容
损伤线粒体传递机制介导成纤维细胞/II型肺泡上皮细胞对话在支气管肺发育不良肺泡发育阻滞中的作用
-
批准号:82371721
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:王星云
-
依托单位:
增强子在小鼠早期胚胎细胞命运决定中的功能和调控机制研究
-
批准号:82371668
-
项目类别:面上项目
-
资助金额:52.00万元
-
批准年份:2023
-
负责人:乔云波
-
依托单位:
MAP2的m6A甲基化在七氟烷引起SST神经元树突发育异常及精细运动损伤中的作用机制研究
-
批准号:82371276
-
项目类别:面上项目
-
资助金额:47.00万元
-
批准年份:2023
-
负责人:严佳
-
依托单位:
"胚胎/生殖细胞发育特性激活”促进“神经胶质瘤恶变”的机制及其临床价值研究
-
批准号:82372327
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:马展
-
依托单位:
Irisin通过整合素调控黄河鲤肌纤维发育的分子机制研究
-
批准号:32303019
-
项目类别:青年科学基金项目
-
资助金额:30.00万元
-
批准年份:2023
-
负责人:职韶阳
-
依托单位:
TMEM30A介导的磷脂酰丝氨酸外翻促进毛细胞-SGN突触发育成熟的机制研究
-
批准号:82371172
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:杨光
-
依托单位:
HER2特异性双抗原表位识别诊疗一体化探针研制与临床前诊疗效能研究
-
批准号:82372014
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:魏伟军
-
依托单位:
水稻边界发育缺陷突变体abnormal boundary development(abd)的基因克隆与功能分析
-
批准号:32070202
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:汪泉
-
依托单位:
Development of a Linear Stochastic Model for Wind Field Reconstruction from Limited Measurement Data
-
批准号:--
-
项目类别:--
-
资助金额:40万元
-
批准年份:2020
-
负责人:Vikrant Gupta
-
依托单位:
细胞核分布基因NudCL2在细胞迁移及小鼠胚胎发育过程中的作用及机制研究
-
批准号:31701214
-
项目类别:青年科学基金项目
-
资助金额:25.0万元
-
批准年份:2017
-
负责人:张雯
-
依托单位: